Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression - Hsieh, Yun-Cheng; Joo, Sae Kyung; Koo, Bo Kyung; Lin, Han-Chieh; Lee, Dong Hyeon; Chang, Mee Soo; Park, Jeong Hwan; So, Young Ho; Kim, Won (Clinical gastroenterology and hepatology, 2023)
Keywords: Fibrosis; Gastroenterology and Hepatology; Humans; Liver - diagnostic imaging; Liver - pathology; Liver Cirrhosis - complications; Muscle Quality; Myocyte; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - epidemiology; Non-alcoholic Fatty Liver Disease - metabolism; Prospective Studies; Sarcopenia; Sarcopenia - complications; Sarcopenia - epidemiology; Steatosis; NAFLD; VATI; ALT; HR; HU; Myocyte; Muscle Quality; Sarcopenia; HDL; MA; hs-CRP; NAFL; BMI; AST; OR; CI; L3; LSM; IQR; NASH; SMI; Steatosis; CT; HOMA-IR; TE; TG; GGT; high-density lipoprotein; alanine aminotransferase; high-sensitivity C-reactive protein; odds ratio; gamma-glutamyl transferase; nonalcoholic steatohepatitis; homeostasis model assessment of insulin resistance; Hounsfield unit; nonalcoholic fatty liver; body mass index; third lumbar vertebra; nonalcoholic fatty liver disease; transient elastography; interquartile range; skeletal muscle index; computed tomography; liver stiffness measurement; visceral adipose tissue index; triglycerides; aspartate aminotransferase; hazard ratio; confidence interval; muscle attenuation